Unknown

Dataset Information

0

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes.


ABSTRACT: Doxorubicin is a potent anticancer drug used to treat a variety of cancer types. However, its use is limited by doxorubicin-induced cardiotoxicity (DIC). A missense variant in the RARG gene (S427L; rs2229774) has been implicated in susceptibility to DIC in a genome wide association study. The goal of this study was to investigate the functional role of this RARG variant in DIC. We used induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) from patients treated with doxorubicin. iPSC-CMs from individuals who experienced DIC (cases) showed significantly greater sensitivity to doxorubicin compared to iPSC-CMs from doxorubicin-treated individuals who did not develop DIC (controls) in cell viability and optical mapping experiments. Using CRISPR/Cas9, we generated isogenic cell lines that differed only at the RARG locus. Genetic correction of RARG-S427L to wild type resulted in reduced doxorubicin-induced double stranded DNA breaks, reactive oxygen species production, and cell death. Conversely, introduction of RARG-S427L increased susceptibility to doxorubicin. Finally, genetic disruption of the RARG gene resulted in protection from cell death due to doxorubicin treatment. Our findings suggest that the presence of RARG-S427L increases sensitivity to DIC, establishing a direct, causal role for this variant in DIC.

SUBMITTER: Christidi E 

PROVIDER: S-EPMC7316788 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Variation in RARG increases susceptibility to doxorubicin-induced cardiotoxicity in patient specific induced pluripotent stem cell-derived cardiomyocytes.

Christidi Effimia E   Huang Haojun H   Shafaattalab Sanam S   Maillet Agnes A   Lin Eric E   Huang Kate K   Laksman Zachary Z   Davis Margot K MK   Tibbits Glen F GF   Brunham Liam R LR  

Scientific reports 20200625 1


Doxorubicin is a potent anticancer drug used to treat a variety of cancer types. However, its use is limited by doxorubicin-induced cardiotoxicity (DIC). A missense variant in the RARG gene (S427L; rs2229774) has been implicated in susceptibility to DIC in a genome wide association study. The goal of this study was to investigate the functional role of this RARG variant in DIC. We used induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) from patients treated with doxorubicin. iPSC-CM  ...[more]

Similar Datasets

| S-EPMC4855185 | biostudies-literature
| S-EPMC9023798 | biostudies-literature
| S-EPMC8642268 | biostudies-literature
| S-EPMC5086256 | biostudies-literature
| S-EPMC4552570 | biostudies-literature
| S-EPMC6111808 | biostudies-other
2016-03-22 | E-GEOD-79413 | biostudies-arrayexpress
| S-EPMC10569550 | biostudies-literature
| S-EPMC9753270 | biostudies-literature
| S-EPMC7156610 | biostudies-literature